BioSpace News Archive

Deals

Revolution Medicines Announces Pricing of Initial Public Offering at $17.00 per share

Revolution Medicines, Inc. announced the pricing of its initial public offering of 14,000,000 shares of common stock at a public offering price of $17.00 per share, before underwriting discounts and commissions.

February 12, 2020
·
3 min read
Policy

Lexington Biosciences License Terminated

Lexington Biosciences, Inc. has allowed the license with the Lawrence Berkeley National Laboratories, which was being used in the HeartSentry technology, to terminate due to non-payment of its minimum annual royalty fees which were due in August 2018 and August 2019..

February 12, 2020
·
2 min read
Deals

AVROBIO Announces Pricing of Underwritten Public Offering of $100 Million of Common Stock

AVROBIO, Inc. announced the pricing of an underwritten public offering of 4,350,000 shares of its common stock at a public offering price of $23.00 per share.

February 12, 2020
·
5 min read